{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:47:03Z","timestamp":1790804823118,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","award":["SP200924002"],"award-info":[{"award-number":["SP200924002"]}],"id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["PO17947"],"award-info":[{"award-number":["PO17947"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014942","name":"Novartis Gene Therapies","doi-asserted-by":"publisher","award":["PS1905"],"award-info":[{"award-number":["PS1905"]}],"id":[{"id":"10.13039\/100014942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SMA is a hereditary neuromuscular disease that causes progressive muscle weakness and atrophy. Several studies have shown that the burden of SMA is very high at many levels. Functional assessment tools currently used do not completely address the impact of the disease in patients\u2019 life. The objective of this qualitative study was to identify aspects of SMA that are relevant to patients and to design items useful for assessment purposes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five focus group sessions were run during an annual SMA families meeting in Madrid, Spain. Focus groups were composed by parents of SMA type I children, sitter children type II-III, parents of sitter children type II-III, adult patients, and parents of walker children. Two trained facilitators conducted the focus groups using a semi-structured guideline to cover previously agreed topics based on the input of a Scientific and Patient Advisory Committee. The guideline was adapted for the different groups. According to what was communicated by participants, SMA entails a high burden of disease for both patients and their parents. Burden was perceived in physical, psychological, and social areas. Patient\u2019s physical domain was the most relevant for participants, especially for parents of non-ambulant children, followed by limitations of motor scales to capture all changes, parents psychological burden, treatment expectations and patient\u2019s psychological burden. Ten domains were the main areas identified as impacted by the disease: mobility and independence, fatigue and fatigability, infections and hospital consultations, scoliosis and contractures, vulnerability, pain, feeding, time spent in care, breathing, and sleep and rest.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study confirms the necessity of evaluating other aspects of the disease that are not assessed in the functional motor scale. Measures of other aspects of the disease, such as pain, fatigue, feeding, should be also considered. A patient-reported outcomes instrument measuring such aspects in a valid and reliable way would be very useful. This study generated a list of new items relevant to be systematically measured in the assessment of the impact of SMA on the patients\u2019 everyday life.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-024-00758-0","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T02:02:57Z","timestamp":1721786577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of the most relevant aspects of spinal muscular atrophy (SMA) with impact on the quality of life of SMA patients and their caregivers: the PROfuture project, a qualitative study"],"prefix":"10.1186","volume":"8","author":[{"given":"Menc\u00eda","family":"de Lemus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-4194","authenticated-orcid":false,"given":"Maria G.","family":"Cattinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel I.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julita","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Magall\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rebollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D\u2019Amico","year":"2011","unstructured":"D\u2019Amico A, Mercuri E, Tiziano FD, Bertini E (2011) Spinal muscular atrophy. Orphanet J Rare Dis 6:71","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"758_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155\u2013165","journal-title":"Cell"},{"issue":"9","key":"758_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/gt.2017.52","volume":"24","author":"K Talbot","year":"2017","unstructured":"Talbot K, Tizzano EF (2017) The clinical landscape for SMA in a new therapeutic era. Gene Ther 24(9):529\u2013533","journal-title":"Gene Ther"},{"issue":"3","key":"758_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","volume":"20","author":"AM Glanzman","year":"2010","unstructured":"Glanzman AM, Mazzone E, Main M, Pelliccioni M, Wood J, Swoboda KJ et al (2010) The children\u2019s hospital of Philadelphia Infant Test of Neuromuscular disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord 20(3):155\u2013161","journal-title":"Neuromuscul Disord"},{"issue":"2 Pt 1","key":"758_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-3476(99)70016-8","volume":"135","author":"L Haataja","year":"1999","unstructured":"Haataja L, Mercuri E, Regev R, Cowan F, Rutherford M, Dubowitz V et al (1999) Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr 135(2 Pt 1):153\u2013161","journal-title":"J Pediatr"},{"key":"758_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","volume":"17","author":"JM O\u2019Hagen","year":"2007","unstructured":"O\u2019Hagen JM, Glanzman AM, McDermott MP, Ryan PA, Flickinger J, Quigley J et al (2007) An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord 17:693\u2013697","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"758_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","volume":"15","author":"C Berard","year":"2005","unstructured":"Berard C, Payan C, Hodgkinson I, Fermanian J, Group MFMCS (2005) A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord 15(7):463\u2013470","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"758_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mus.25430","volume":"55","author":"ES Mazzone","year":"2017","unstructured":"Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Young SD et al (2017) Revised upper limb module for spinal muscular atrophy: development of a new module. Muscle Nerve 55(6):869\u2013874","journal-title":"Muscle Nerve"},{"issue":"1","key":"758_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12883-017-0853-y","volume":"17","author":"S McGraw","year":"2017","unstructured":"McGraw S, Qian Y, Henne J, Jarecki J, Hobby K, Yeh WS (2017) A qualitative study of perceptions of meaningful change in spinal muscular atrophy. BMC Neurol 17(1):68","journal-title":"BMC Neurol"},{"issue":"13","key":"758_CR10","doi-asserted-by":"publisher","first-page":"e1206","DOI":"10.1212\/WNL.0000000000006241","volume":"91","author":"P Mongiovi","year":"2018","unstructured":"Mongiovi P, Dilek N, Garland C, Hunter M, Kissel JT, Luebbe E et al (2018) Patient reported impact of symptoms in spinal muscular atrophy (PRISM-SMA). Neurology 91(13):e1206\u2013e14","journal-title":"Neurology"},{"issue":"5","key":"758_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","volume":"27","author":"F Rouault","year":"2017","unstructured":"Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P et al (2017) Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients. Neuromuscul Disord 27(5):428\u2013438","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"758_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JND-200534","volume":"7","author":"VA Sansone","year":"2020","unstructured":"Sansone VA, Walter MC, Attarian S, Delstanche S, Mercuri E, Lochmuller H et al (2020) Measuring outcomes in adults with spinal muscular atrophy - challenges and future directions - meeting report. J Neuromuscul Dis 7(4):523\u2013534","journal-title":"J Neuromuscul Dis"},{"issue":"12","key":"758_CR13","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s11136-018-1945-x","volume":"27","author":"S Vaidya","year":"2018","unstructured":"Vaidya S, Boes S (2018) Measuring quality of life in children with spinal muscular atrophy: a systematic literature review. Qual Life Res 27(12):3087\u20133094","journal-title":"Qual Life Res"},{"issue":"5","key":"758_CR14","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mus.25148","volume":"54","author":"ET Kruitwagen-Van Reenen","year":"2016","unstructured":"Kruitwagen-Van Reenen ET, Wadman RI, Visser-Meily JM, van den Berg LH, Schroder C, van der Pol WL (2016) Correlates of health-related quality of life in adult patients with spinal muscular atrophy. Muscle Nerve 54(5):850\u2013855","journal-title":"Muscle Nerve"},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh WS (2015) Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol 15:217","journal-title":"BMC Neurol"},{"issue":"4","key":"758_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JND-200611","volume":"8","author":"MC Walter","year":"2021","unstructured":"Walter MC, Chiriboga C, Duong T, Goemans N, Mayhew A, Ouillade L et al (2021) Improving care and empowering adults living with SMA: a call to action in the New Treatment Era. J Neuromuscul Dis 8(4):543\u2013551","journal-title":"J Neuromuscul Dis"},{"key":"758_CR17","doi-asserted-by":"crossref","unstructured":"Mercuri E, Messina S, Montes J, Muntoni F, Sansone VA, all p, et al. (2020) Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019. Neuromuscul Disord 30(5):431\u2013436","DOI":"10.1016\/j.nmd.2020.02.019"},{"issue":"2","key":"758_CR18","first-page":"239","volume":"10","author":"J Slayter","year":"2023","unstructured":"Slayter J, Casey L, O\u2019Connell C (2023) Patient reported outcome measures in adult spinal muscular atrophy: a scoping review and graphical visualization of the evidence. J Neuromuscul Dis 1 de enero de 10(2):239\u2013250","journal-title":"J Neuromuscul Dis 1 de enero de"},{"key":"758_CR19","doi-asserted-by":"crossref","unstructured":"Voet N, Pater R, Garmendia J, Sistiaga A, Labayru G, Gallais B et al (2024) Patient-reported outcome measures in Neuromuscular Diseases: a scoping review. J Neuromuscul Dis 19 de marzo de;1\u201311","DOI":"10.3233\/JND-240003"},{"issue":"1","key":"758_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40120-022-00411-2","volume":"12","author":"JF V\u00e1zquez-Costa","year":"2023","unstructured":"V\u00e1zquez-Costa JF, Branas-Pampill\u00f3n M, Medina-Cantillo J et al (2023) Validation of a set of instruments to assess patient- and caregiver-oriented measurements in spinal muscular atrophy: results of the SMA-TOOL study. Neurol Therapy 12(1):89\u2013105","journal-title":"Neurol Therapy"},{"issue":"6","key":"758_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mus.27223","volume":"63","author":"CE Zizzi","year":"2021","unstructured":"Zizzi CE, Luebbe E, Mongiovi P, Hunter M, Dilek N, Garland C et al (2021) The spinal muscular Atrophy Health Index: a novel outcome for measuring how a patient feels and functions. Muscle Nerve 63(6):837\u2013844","journal-title":"Muscle Nerve"},{"key":"758_CR22","doi-asserted-by":"crossref","unstructured":"Lieber E, Weisner T (2010) Meeting the practical challenges of mixed methods research. In: Tashakkori A, Teddlie C (eds) SAGE handbook of mixed methods in social and behavioral research. SAGE Publications, Inc, pp 559\u2013580","DOI":"10.4135\/9781506335193.n22"},{"key":"758_CR23","unstructured":"Lieber E, Weisner T (2012) Dedoose. https:\/\/www.dedoose.com"},{"issue":"4","key":"758_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/msc.94","volume":"4","author":"KL Haywood","year":"2006","unstructured":"Haywood KL (2006) Patient-reported outcome I: measuring what matters in musculoskeletal care. Musculoskelet Care 4(4):187\u2013203","journal-title":"Musculoskelet Care"},{"issue":"1","key":"758_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hex.12442","volume":"20","author":"B Wiering","year":"2017","unstructured":"Wiering B, de Boer D, Delnoij D (2017) Patient involvement in the development of patient-reported outcome measures: a scoping review. Health Expect 20(1):11\u201323","journal-title":"Health Expect"},{"issue":"Suppl 2","key":"758_CR26","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1111\/j.1524-4733.2007.00271.x","volume":"10","author":"RR Turner","year":"2007","unstructured":"Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, Mayo FDAP-ROCMG (2007) Patient-reported outcomes: instrument development and selection issues. Value Health 10 Suppl 2:S86\u201393","journal-title":"Value Health"},{"key":"758_CR27","doi-asserted-by":"publisher","first-page":"2329048X2110087","DOI":"10.1177\/2329048X211008725","volume":"8","author":"K Pierzchlewicz","year":"2021","unstructured":"Pierzchlewicz K, Kepa I, Podogrodzki J, Kotulska K (2021) Spinal muscular atrophy: the use of functional motor scales in the era of disease-modifying treatment. Child Neurol Open 8:2329048X211008725","journal-title":"Child Neurol Open"},{"issue":"12","key":"758_CR28","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/ene.15542","volume":"29","author":"JF V\u00e1zquez-Costa","year":"2022","unstructured":"V\u00e1zquez-Costa JF, Povedano M, Nascimiento\u2010Osorio AE, Moreno Escribano A, Kapetanovic Garcia S, Dominguez R et al (2022) Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy. Eur J Neurol Diciembre De 29(12):3666\u20133675","journal-title":"Eur J Neurol Diciembre De"},{"key":"758_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M et al (2004) Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:12","journal-title":"Health Qual Life Outcomes"},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"175628642199890","DOI":"10.1177\/1756286421998902","volume":"14","author":"A Osmanovic","year":"2021","unstructured":"Osmanovic A, Ranxha G, Kumpe M, Wurster CD, Stolte B, Cordts I et al (2021) Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy. Ther Adv Neurol Disord 14:1756286421998902","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"758_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13010-019-0075-6","volume":"14","author":"J Boldt","year":"2019","unstructured":"Boldt J (2019) The concept of vulnerability in medical ethics and philosophy. Philos Ethics Humanit Med 14(1):6","journal-title":"Philos Ethics Humanit Med"},{"key":"758_CR32","unstructured":"Cambridge Dictionary: Cambridge University Press (2022) [https:\/\/dictionary.cambridge.org\/dictionary\/english\/vulnerability]"},{"issue":"5","key":"758_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nmd.2021.02.006","volume":"31","author":"VA Sansone","year":"2021","unstructured":"Sansone VA, Pirola A, Lizio A, Greco LC, Coratti G, Casiraghi J et al (2021) The spinal muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure. Neuromuscul Disord 31(5):409\u2013418","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"758_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mus.27785","volume":"67","author":"R Sadjadi","year":"2023","unstructured":"Sadjadi R, Kelly K, Glanzman AM, Montes J, Linsenmayer M, Tellez M et al (2023) Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis. Muscle Nerve marzo de 67(3):239\u2013243","journal-title":"Muscle Nerve marzo de"},{"key":"758_CR35","doi-asserted-by":"publisher","first-page":"104851","DOI":"10.1016\/j.earlhumdev.2019.104851","volume":"138","author":"EF Tizzano","year":"2019","unstructured":"Tizzano EF (2019) Treating neonatal spinal muscular atrophy: a 21st century success story? Early Hum Dev 138:104851","journal-title":"Early Hum Dev"},{"key":"758_CR36","unstructured":"[Pharmacoclinical protocol for treatment of patients with spinal muscular atrophy 5q with the drug spinraza] Ministerio de Sanidad, Servicios Sociales e Igualdad; 2018 [cited 2021 November 11th]. http:\/\/genm.sen.es\/attachments\/article\/164\/protocolo_tratamiento_nusinersen_ame.pdf"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-024-00758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-024-00758-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-024-00758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T02:03:06Z","timestamp":1721786586000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-024-00758-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1186\/s41687-024-00758-0","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the Hospital Universitario La Paz, and all participants signed the informed consent form to participate in the study and to record all meetings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}